Doctors News Hubb
Advertisement Banner
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us
No Result
View All Result
Doctors News Hubb
No Result
View All Result
Home News

Transdermal Testosterone Pretreatment Improves Live Birth Rates in Poor Responders

admin by admin
March 22, 2023
in News


The following is a summary of the “Higher live birth rate following transdermal testosterone pretreatment in poor responders: a systematic review and meta-analysis,” published in the Jan 2023 issue of Reproductive Biomedicine Online by Katsika, et al.


To find high-quality RCTs evaluating testosterone pretreatment in poor responders, a systematic review and meta-analysis was conducted. There were eight randomized controlled trials examined, totaling 797 female participants. All studies used a transdermal testosterone gel of 10-12.5 mg daily for 10-56 days. Clinical pregnancy or live birth was used as the primary outcome measure. 

The number of cumulus-oocyte complexes retrieved was also significantly higher after testosterone pretreatment (RR 2.07, 95% CI 1.09-3.92), as was the likelihood of a live birth (RR 2.25, 95% CI 1.54-3.30). The number of days needed to complete ovarian stimulation, the total dose of gonadotrophins, the cancellation rate due to poor ovarian response, and the thickness of the endometrium on the day of the trigger for final oocyte maturation all decreased significantly. 

They found no statistically significant differences in oestradiol levels, the number of follicles 17 mm, metaphase II oocytes,2-pronuclear oocytes and embryos transferred, or the percentage of patients who underwent embryo transfer. According to the results of the current study, pretreatment with transdermal testosterone increases the likelihood of pregnancy in poor responders undergoing ovarian stimulation for IVF.

Source: sciencedirect.com/science/article/abs/pii/S1472648322007179



Source link

Advertisement Banner
Previous Post

Stress Management for First Responders

Next Post

Interview with Ogi Kavazovic, CEO of House Rx – The Health Care Blog

Related Posts

News

Factors Associated with Recurrences or Relapses in Individuals Diagnosed with GCA

June 1, 2023
News

Examining Independently Billed Dermatologic Procedures by Nonphysician Practitioners in the US

May 31, 2023
News

Long-Term Use of Antiseizure Medication and the Risk of Developing Type 2 Diabetes Mellitus

May 30, 2023
News

TC Response in IBD Children Treated with Infliximab and Adalimumab After Treatment Adjustment

May 29, 2023
News

Spironolactone may be effective in the treatment of acne vulgaris

May 28, 2023
News

Quizartinib improves overall median survival in patients with acute myeloid leukemia

May 27, 2023
Next Post

Interview with Ogi Kavazovic, CEO of House Rx – The Health Care Blog

Recommended

Practicing at the Top of Your License is Not an Option for Primary Care Physicians – The Health Care Blog

3 months ago

Judge halts FDA approval of abortion pill mifepristone

2 months ago

A Father-Son Interview – The Health Care Blog

4 months ago

Best Places to Work in Healthcare – 2023 (alphabetical list)

3 weeks ago

Extended Mortality Risks in Children with Inborn Metabolic Errors

3 months ago

© Doctors News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Healthcare
  • Public Health
  • Paramedic
  • Nursing
  • Contact Us

© 2022 Doctors News Hubb All rights reserved.